These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 7823975

  • 1. Nerve conduction changes and fine structural alterations of extra- and intrafusal muscle and nerve fibers in streptozotocin diabetic rats.
    Weis J, Dimpfel W, Schröder JM.
    Muscle Nerve; 1995 Feb; 18(2):175-84. PubMed ID: 7823975
    [Abstract] [Full Text] [Related]

  • 2. Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats.
    Mizisin AP, Calcutt NA, Tomlinson DR, Gallagher A, Fernyhough P.
    J Peripher Nerv Syst; 1999 Feb; 4(3-4):211-21. PubMed ID: 10642089
    [Abstract] [Full Text] [Related]

  • 3. Quantitative morphometric study of the skeletal muscles of normal and streptozotocin-diabetic rats.
    Aughsteen AA, Khair AM, Suleiman AA.
    JOP; 2006 Jul 10; 7(4):382-9. PubMed ID: 16832135
    [Abstract] [Full Text] [Related]

  • 4. Streptozotocin induced diabetes as a model of phrenic nerve neuropathy in rats.
    Rodrigues Filho OA, Fazan VP.
    J Neurosci Methods; 2006 Mar 15; 151(2):131-8. PubMed ID: 16125783
    [Abstract] [Full Text] [Related]

  • 5. Distal neuropathy in experimental diabetes mellitus.
    Brown MJ, Sumner AJ, Greene DA, Diamond SM, Asbury AK.
    Ann Neurol; 1980 Aug 15; 8(2):168-78. PubMed ID: 7425570
    [Abstract] [Full Text] [Related]

  • 6. Peripheral neuropathy in the WBN/Kob rat with chronic pancreatitis and spontaneous diabetes.
    Yagihashi S, Wada R, Kamijo M, Nagai K.
    Lab Invest; 1993 Mar 15; 68(3):296-307. PubMed ID: 8383778
    [Abstract] [Full Text] [Related]

  • 7. Aminoguanidine--effects on endoneurial vasoactive nitric oxide and on motor nerve conduction velocity in control and streptozotocin-diabetic rats.
    Dewhurst M, Omawari N, Tomlinson DR.
    Br J Pharmacol; 1997 Feb 15; 120(4):593-8. PubMed ID: 9051296
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of the Ca2+ antagonist nimodipine on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats.
    Biessels GJ, ter Laak MP, Kamal A, Gispen WH.
    Brain Res; 2005 Feb 21; 1035(1):86-93. PubMed ID: 15713280
    [Abstract] [Full Text] [Related]

  • 11. [Study on the latency difference between compound muscle and sensory nerve action potentials].
    Hasegawa O, Gondo G, Wada N, Matsumoto S, Mimura E.
    No To Shinkei; 2001 Jun 21; 53(6):541-5. PubMed ID: 11436338
    [Abstract] [Full Text] [Related]

  • 12. Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats.
    Yagihashi S, Kamijo M, Watanabe K.
    Am J Pathol; 1990 Jun 21; 136(6):1365-73. PubMed ID: 2141449
    [Abstract] [Full Text] [Related]

  • 13. The rat caudal nerves: a model for experimental neuropathies.
    Schaumburg HH, Zotova E, Raine CS, Tar M, Arezzo J.
    J Peripher Nerv Syst; 2010 Jun 21; 15(2):128-39. PubMed ID: 20626776
    [Abstract] [Full Text] [Related]

  • 14. Contraction-induced muscle fiber damage is increased in soleus muscle of streptozotocin-diabetic rats and is associated with elevated expression of brain-derived neurotrophic factor mRNA in muscle fibers and activated satellite cells.
    Copray S, Liem R, Brouwer N, Greenhaff P, Habens F, Fernyhough P.
    Exp Neurol; 2000 Feb 21; 161(2):597-608. PubMed ID: 10686079
    [Abstract] [Full Text] [Related]

  • 15. Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats.
    Hasegawa T, Kosaki A, Shimizu K, Matsubara H, Mori Y, Masaki H, Toyoda N, Inoue-Shibata M, Nishikawa M, Iwasaka T.
    Exp Neurol; 2006 Jun 21; 199(2):274-80. PubMed ID: 16337192
    [Abstract] [Full Text] [Related]

  • 16. Sulodexide prevents peripheral nerve damage in streptozotocin induced diabetic rats.
    Jin HY, Lee KA, Song SK, Liu WJ, Choi JH, Song CH, Baek HS, Park TS.
    Eur J Pharmacol; 2012 Jan 15; 674(2-3):217-26. PubMed ID: 21641343
    [Abstract] [Full Text] [Related]

  • 17. Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor.
    Manschot SM, Gispen WH, Kappelle LJ, Biessels GJ.
    Diabetes Metab Res Rev; 2003 Jan 15; 19(6):469-77. PubMed ID: 14648806
    [Abstract] [Full Text] [Related]

  • 18. Phrenic nerve diabetic neuropathy in rats: unmyelinated fibers morphometry.
    Fazan VP, Rodrigues Filho OA, Jordão CE, Moore KC.
    J Peripher Nerv Syst; 2009 Jun 15; 14(2):137-45. PubMed ID: 19691536
    [Abstract] [Full Text] [Related]

  • 19. Effect of gangliosides on nerve conduction velocity during diabetic neuropathy in the rat.
    Spüler M, Dimpfel W, Tüllner HU.
    Arch Int Pharmacodyn Ther; 1987 Jun 15; 287(2):211-23. PubMed ID: 3307667
    [Abstract] [Full Text] [Related]

  • 20. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.
    Drel VR, Mashtalir N, Ilnytska O, Shin J, Li F, Lyzogubov VV, Obrosova IG.
    Diabetes; 2006 Dec 15; 55(12):3335-43. PubMed ID: 17130477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.